01
Cancer Type
Ovarian, cervical, endometrial, uterine, vaginal and vulvar cancers can require different diagnostic and treatment approaches.
Gynaecological cancers include cancers affecting the ovaries, cervix, uterus, vagina and vulva. Diagnosis and treatment depend on the specific cancer, its stage, tumour characteristics and the individual's overall health.
Gynaecological cancer refers to a group of cancers that develop in organs of the female reproductive system. These cancers are not all the same and can behave differently depending on where they begin and their biological characteristics.
The major types include ovarian, cervical, endometrial and other uterine cancers, as well as less common cancers of the vagina and vulva.
Some symptoms can overlap with common gynaecological conditions. Persistent or unusual symptoms should therefore be evaluated by a qualified healthcare professional rather than assumed to be cancer or dismissed without assessment.
There is no single treatment plan for every gynaecological cancer. The approach is selected according to the cancer type, extent of disease and individual clinical factors.
Ovarian, cervical, endometrial, uterine, vaginal and vulvar cancers can require different diagnostic and treatment approaches.
Staging describes the extent of cancer and whether it has spread to nearby tissues, lymph nodes or distant parts of the body.
Microscopic examination of tissue helps establish the cancer type, grade and other characteristics relevant to treatment.
Certain cancers may require additional molecular, genetic or biomarker information to help guide treatment decisions.
Age, general health, other medical conditions, previous treatment and functional status can influence treatment choices.
The treatment plan also considers whether the goal is cure, disease control, symptom management or another clinically appropriate objective.
Depending on the diagnosis and treatment plan, gynaecological cancer care may involve more than one oncology specialty. Surgical, medical and radiation oncologists can contribute at different stages of treatment.
Evaluates the role of cancer surgery, including removal of the tumour and appropriate surrounding tissues or lymph nodes when surgery is indicated.
Evaluates systemic treatments such as chemotherapy, targeted therapy, hormone therapy or immunotherapy when clinically appropriate.
Assesses whether radiation therapy is appropriate and develops a treatment plan based on the cancer location, stage and surrounding normal tissues.
Bring your reports, scans and previous treatment records for an oncology consultation at Precision Oncology Clinic, Vijayanagar, Bengaluru.
Gynaecological cancers do not all cause the same symptoms. Some may cause abnormal vaginal bleeding or discharge, while others may present with pelvic pressure, abdominal symptoms, urinary or bowel changes, or changes affecting the vulva.
Some gynaecological cancers may cause few or no symptoms in their early stages. Paying attention to changes that are unusual for you can help you know when medical assessment is appropriate.
These symptoms can occur for many reasons, but persistent or unusual changes should be discussed with a healthcare professional.
Each gynaecological cancer has its own pattern of symptoms. Some symptoms overlap between different cancers.
Possible symptoms include persistent bloating, abdominal or pelvic pain or pressure, feeling full quickly, difficulty eating and changes in urination or bowel habits.
Cervical cancer may have no symptoms early on. When symptoms occur, they can include unusual vaginal bleeding, including bleeding after sex, or unusual vaginal discharge.
Unusual vaginal bleeding or discharge is an important warning sign. Pelvic pain or pressure can also occur.
Possible symptoms include unusual vaginal bleeding or discharge, pelvic pain and changes in urinary or bowel habits.
Symptoms can include persistent itching, burning, bleeding, changes in vulval skin, sores, ulcers, lumps or persistent pain.
Many of these symptoms can be caused by non-cancerous conditions. Medical evaluation is needed to understand what is causing a persistent or unusual change.
Unusual vaginal bleeding should be medically assessed, particularly bleeding after menopause. Other unexplained symptoms that persist should also be evaluated rather than being assumed to be a routine gynaecological problem.
Screening is performed in people without symptoms to look for a disease before it becomes apparent. Diagnostic evaluation is used when symptoms or other findings require investigation.
Cervical cancer is the main gynaecological cancer for which established screening tests are available. Depending on local guidelines and individual circumstances, HPV testing and cervical cytology may be used.
A person with unusual bleeding, persistent pelvic symptoms, abdominal changes or other concerning findings may need diagnostic assessment rather than relying on a screening test.
If you have unusual bleeding, persistent pelvic or abdominal symptoms, unexplained bloating, unusual discharge or another concerning change, discuss it with a qualified healthcare professional.
Diagnosing gynaecological cancer usually involves combining information from the patient's symptoms, medical history, physical examination, imaging, laboratory investigations and, when required, tissue examination.
There is no single test that can diagnose every type of cancer. The investigations selected depend on the symptoms, suspected cancer type and findings from the initial assessment.
The exact sequence varies, but doctors generally build the diagnosis step by step using clinical findings, investigations and pathology.
Symptoms, medical history, family history and relevant risk factors are reviewed, followed by an appropriate physical or pelvic examination.
Depending on the suspected cancer, doctors may request blood tests, ultrasound or other imaging to investigate an abnormal finding.
When required, a biopsy or surgical specimen is examined by a pathologist to determine whether cancer is present and identify its characteristics.
Additional tests may determine the extent of disease and whether it has spread to nearby or distant areas.
Not every patient needs every test. The choice depends on the suspected cancer and the findings from the initial evaluation.
A physical or pelvic examination can help identify abnormalities involving the vagina, cervix, uterus, ovaries or surrounding pelvic structures.
Pelvic or transvaginal ultrasound may be used to assess the uterus, ovaries and other pelvic structures when clinically indicated.
CT imaging can provide information about the pelvis, abdomen and other areas when assessment of the extent of disease is required.
MRI can provide detailed images of pelvic structures and may be useful for evaluating selected gynaecological cancers.
PET-CT combines metabolic and anatomical imaging and may be used in selected situations to assess disease extent.
Certain blood tests or tumour markers may support diagnosis, treatment planning or monitoring in selected cancers. Results are interpreted together with other clinical information.
The investigations used depend on where the cancer is suspected and what needs to be established before treatment.
Evaluation may include pelvic examination, ultrasound and other imaging such as CT or MRI. Blood tests including CA-125 may be used in selected situations. Tissue diagnosis is important for establishing the cancer type.
Evaluation may include examination of the cervix, biopsy and procedures such as colposcopy, LEEP or cone biopsy in selected circumstances. Imaging may then be used to assess the extent of confirmed disease.
Evaluation may include pelvic examination, imaging and sampling of the endometrium. Tissue examination helps determine the histological type and other characteristics of the cancer.
Evaluation usually begins with examination of the affected area. A biopsy may be performed when a suspicious lesion needs tissue diagnosis, followed by additional investigations when staging is required.
A biopsy removes a sample of tissue so that a pathologist can examine it under a microscope and perform additional tests when necessary. In many cancers, tissue examination is needed to establish a definitive diagnosis.
A pathology report can identify the type of cancer and provide information about features such as histological characteristics and grade.
Depending on the cancer, additional biomarker or molecular testing may provide information that can influence treatment planning.
The pathology report is therefore an important part of the overall treatment decision-making process.
Pathology helps transform a suspicious finding into a more precise understanding of the cancer.
The report identifies the histological type of cancer and may distinguish between different tumour subtypes.
Grade describes how abnormal the cancer cells appear under the microscope. Grade and stage are different measurements.
Tissue obtained during surgery may provide information about local invasion, margins or lymph-node involvement when these structures are sampled.
Selected gynaecological cancers may require additional molecular or biomarker testing to help classify disease or guide treatment.
Staging describes the extent of cancer in the body. It helps doctors understand whether the cancer is confined to its original location, has involved nearby tissues or lymph nodes, or has spread to distant parts of the body.
Knowing the stage is an important part of selecting an appropriate treatment strategy.
Understanding why a test has been recommended can make the diagnostic process easier to navigate. Bring your reports and imaging to your oncology consultation so the available information can be reviewed together.
Treatment for gynaecological cancer depends on the type of cancer, stage, tumour characteristics, previous treatment, overall health and the goals of care.
Some patients may need one main treatment, while others may receive a combination of surgery, chemotherapy, radiation therapy, targeted treatment or immunotherapy.
Depending on the cancer and stage, treatment may involve one or more of the following approaches.
Different gynaecological cancers have different treatment pathways. The following gives a general overview rather than an individual treatment recommendation.
Treatment commonly involves surgery and systemic treatment. Depending on stage and circumstances, chemotherapy may be given before or after surgery. Selected patients may also be considered for targeted therapies or clinical trials.
Surgery Chemotherapy Targeted TherapyTreatment depends strongly on stage and tumour characteristics. Options may include surgery, radiation therapy, chemotherapy, concurrent chemoradiation and selected systemic treatments.
Surgery Radiation Chemotherapy ImmunotherapySurgery is a common primary treatment. Depending on stage, grade, histology and molecular characteristics, additional radiation, chemotherapy, hormone therapy, targeted treatment or immunotherapy may be considered.
Surgery Radiation Chemotherapy Hormone TherapyTreatment may involve surgery and/or radiation therapy depending on the location, size and stage of the cancer. Systemic treatment may be considered in selected advanced situations.
Surgery Radiation Systemic TreatmentDoctors consider multiple pieces of information before recommending a treatment pathway. The aim is to match treatment intensity and sequence to the patient's cancer and circumstances.
Treatment does not always follow the same order. The sequence is selected according to the cancer type, stage and treatment goal.
In selected cancers, systemic treatment or other therapy may be given before surgery to reduce or control disease before an operation.
When surgery is appropriate as the initial treatment, the operation may remove the primary cancer and provide additional pathological information.
Depending on the pathology and risk of recurrence, chemotherapy, radiation therapy or another treatment may be recommended after surgery.
Advanced or recurrent disease may require systemic treatment, radiation, symptom control and supportive or palliative care according to individual needs.
A diagnosis such as ovarian or cervical cancer is only the starting point. The treatment plan is developed after reviewing the complete clinical and pathological picture.
When more than one treatment approach is possible, patients should understand the purpose, expected benefits, possible side effects and practical implications of each option.
Bring your biopsy or pathology report, scan reports, previous treatment records and medication list to your oncology consultation. These documents can help the cancer team understand your diagnosis and discuss the next steps.
Surgery is an important treatment for several gynaecological cancers. The type and extent of surgery depend on the cancer type, stage, tumour location, pathology, fertility considerations and the overall treatment plan.
In some situations surgery is the main treatment. In others, it may be combined with chemotherapy or radiation therapy before or after the operation.
The procedure selected depends on the location and extent of cancer and the purpose of surgery.
Removal of the uterus. Depending on the cancer and operation, the cervix and other nearby structures may also be removed.
Removal of one or both ovaries together with the corresponding fallopian tube(s), when clinically indicated.
Surgery for ovarian cancer may involve removal of visible disease and assessment of the abdomen and pelvis as part of cancer staging and treatment.
Depending on stage, procedures may range from conization or selected fertility-preserving surgery to hysterectomy.
Selected vulvar cancers may be treated with local excision or more extensive surgery depending on tumour size, location and depth of invasion.
Selected vaginal cancers may be treated with local excision, partial or more extensive removal of vaginal tissue, depending on tumour location and extent.
A gynaecological oncology operation is planned around the anatomy, stage and biology of the particular cancer.
Surgery may include removal of the uterus, ovaries and fallopian tubes when appropriate, together with removal or assessment of visible disease and relevant staging procedures.
The extent of surgery depends on whether the disease appears confined to the pelvis or has spread elsewhere in the abdomen.
Selected early cervical cancers may be treated with procedures such as conization or fertility-preserving surgery. Other patients may require hysterectomy or non-surgical treatment depending on stage.
Lymph-node assessment may form part of surgical staging in appropriate patients.
Surgery commonly involves removal of the uterus and may include removal of both ovaries and fallopian tubes. Lymph-node assessment may be performed depending on the patient's risk and disease characteristics.
Surgery may range from local excision to more extensive procedures depending on tumour location, size, depth and spread. Lymph-node assessment may be considered for selected vulvar or vaginal cancers.
Lymph nodes are part of the body's lymphatic system. Some gynaecological cancers can spread to regional lymph nodes, so assessing them can provide important information about the extent of disease.
In selected cancers, the first lymph node or nodes that drain the tumour area may be identified and examined for cancer cells.
In selected situations, a group of regional lymph nodes may be surgically removed and examined by pathology.
Lymph-node findings can contribute to staging and may influence decisions about treatment after surgery.
The need for lymph-node assessment depends on the cancer type, stage, tumour characteristics and the planned operation.
For some younger patients with selected early-stage gynaecological cancers, preserving fertility may be possible. This depends strongly on the cancer type, stage, pathology and treatment goals.
Fertility preservation should be discussed before treatment whenever future pregnancy is important to the patient.
The surgical approach is selected according to the cancer, complexity of the procedure, patient factors and the surgeon's assessment of what provides appropriate cancer treatment.
Laparoscopic surgery uses small abdominal incisions and specialised instruments. It may be appropriate for selected gynaecological cancer operations.
Robotic-assisted surgery is a form of minimally invasive surgery that uses a robotic surgical system controlled by the surgeon. Its suitability depends on the specific operation and patient.
Open surgery uses a larger abdominal incision and may be required for some complex procedures or when the extent of disease makes an open approach more appropriate.
A minimally invasive approach is not automatically appropriate simply because it uses smaller incisions. Cancer control and the ability to perform the required operation safely remain central to surgical planning.
Tissue removed during surgery is examined by a pathologist. The final pathology can provide information that helps determine whether additional treatment is needed.
If surgery has been recommended, bring your biopsy or pathology report, imaging, previous treatment records and relevant medical documents to your consultation. Understanding the purpose and extent of surgery can help you make informed decisions about care.
Not all gynaecological cancers are treated with surgery alone. Medicines and radiation therapy may be used before surgery, after surgery, together with other treatments, or as the main treatment when surgery is not appropriate.
The choice depends on the cancer type, stage, pathology, molecular or biomarker findings, previous treatment and the patient's overall health.
Systemic treatments work throughout the body. Different medicines are selected according to the cancer type and its biological characteristics.
Chemotherapy uses anti-cancer medicines to destroy cancer cells or interfere with their growth and division. It may be given before or after surgery, with radiation, or for advanced or recurrent disease.
Targeted medicines act on specific proteins, pathways or biological processes involved in cancer growth. Their use depends on the cancer type and relevant tumour characteristics.
Immunotherapy helps the immune system recognise or attack cancer cells. Biomarker testing may help determine whether selected immunotherapies are appropriate.
Hormone-based treatment may be used for selected hormone-sensitive gynaecological cancers, particularly certain endometrial cancers.
In selected cancers, treatment may continue after an initial response or completion of primary therapy to help control the disease for longer.
Clinical trials may provide access to new treatments or new combinations of existing treatments for appropriately selected patients.
Radiation therapy uses high-energy radiation to damage cancer cells and control their growth. It can be used as part of curative treatment, after surgery, together with chemotherapy, or to relieve symptoms in selected advanced cancers.
Radiation is delivered from a machine outside the body to a planned treatment area. Modern planning techniques can help shape the radiation dose around the target while limiting exposure to nearby organs.
Brachytherapy is internal radiation therapy in which a radioactive source is placed in or close to the area requiring treatment. It is particularly important in selected cervical and vaginal cancers and may be used in some endometrial cancer situations.
Advanced radiation planning can shape radiation dose more precisely around the treatment target. Techniques such as IMRT may help reduce radiation exposure to nearby healthy tissues.
In selected advanced cancers, radiation can also be used to relieve symptoms caused by a tumour, with treatment planned around the patient's clinical needs.
Radiation treatment is planned around the tumour location, stage, previous treatment and the organs surrounding the treatment area.
Imaging is used to map the treatment area and help the radiation oncology team define the target and nearby organs that need to be considered.
Computer-based planning determines how radiation is delivered to the intended treatment area while taking surrounding normal tissues into account.
External radiation is commonly divided into multiple treatment sessions, or fractions, according to the prescribed treatment schedule.
For brachytherapy, the applicator and radiation source are positioned according to the anatomy and treatment target.
These are general treatment patterns. The actual treatment plan depends on the patient's stage, pathology, biomarkers and clinical circumstances.
Systemic treatment is an important part of ovarian cancer care. Chemotherapy may be combined with surgery, while selected patients may receive targeted treatments such as PARP inhibitors or anti-angiogenic therapy depending on disease characteristics and treatment setting.
Radiation therapy may be combined with chemotherapy for locally advanced cervical cancer. External radiation and brachytherapy are important components of treatment in appropriate patients. Selected advanced or recurrent cancers may also be treated with immunotherapy or targeted treatment.
Depending on stage, grade, histology and molecular characteristics, treatment may include radiation, chemotherapy, hormone therapy, targeted therapy or immunotherapy. Treatment may be combined with surgery.
Radiation therapy may be used as a primary treatment or after surgery in selected patients. Chemotherapy may be combined with radiation in particular clinical situations, especially when disease is locally advanced.
Cancer treatment may use different modalities because surgery, radiation and systemic medicines address cancer in different ways. Combining treatments can be appropriate when the cancer requires both local and systemic control.
Side effects vary according to the treatment, dose, treatment area and individual patient. They should be discussed with the treating oncology team rather than managed without medical advice.
Bring your pathology report, imaging reports, previous treatment records and current medication list to your oncology consultation. Your treatment team can explain why a particular combination of treatments has been recommended and what to expect during therapy.
A cancer diagnosis is only the beginning of the treatment planning process. Your oncology team brings together the diagnosis, stage, pathology, imaging, tumour characteristics, medical history and individual priorities before developing a treatment plan.
Depending on the cancer, care may involve surgical oncology, medical oncology, radiation oncology and other healthcare professionals working together.
Your treatment pathway may change as additional pathology, imaging or treatment-response information becomes available.
Review the pathology, imaging and clinical findings to establish the cancer type and relevant characteristics.
Determine the stage and whether the disease involves nearby tissues, lymph nodes or distant sites.
Consider surgery, systemic treatment, radiation and other appropriate options in the context of the individual diagnosis.
Treatment is delivered according to the agreed plan, with monitoring for response, side effects and changing clinical needs.
Follow-up helps monitor recovery, treatment effects, ongoing health needs and signs that require further assessment.
Gynaecological cancer treatment can involve more than one oncology speciality. Each specialist contributes to a different part of diagnosis, treatment planning or ongoing care.
Consultant Surgical Oncologist. Surgical assessment and cancer surgery may form part of the treatment pathway when an operation is appropriate.
Consultant Medical Oncologist and Haematologist. Systemic treatments such as chemotherapy, targeted treatment and selected immunotherapies may form part of medical oncology care.
Consultant Radiation Oncologist. Radiation treatment, including external radiation and selected brachytherapy approaches, may be considered according to the diagnosis.
Understanding the purpose, benefits, risks and practical implications of treatment can help you participate in decisions about your care.
A second opinion allows another cancer specialist to review the available information and provide an independent medical assessment of the diagnosis or proposed treatment plan.
The second specialist may agree with the original plan, suggest modifications or discuss another treatment approach.
Seeking another opinion can be particularly useful when the diagnosis is complex, major surgery is being considered, or you want to understand available treatment options before starting therapy.
Completing active treatment does not mean that medical follow-up ends. A follow-up plan is developed according to the cancer type, treatment received and individual health needs.
Having your medical records together can make it easier for the oncology team to review your diagnosis and previous care.
Bring your pathology, imaging and previous treatment records for a detailed oncology consultation. The treatment approach can then be discussed in the context of your cancer type, stage, tumour characteristics and individual priorities.
Answers to common questions about symptoms, diagnosis, treatment, surgery, radiation, second opinions and follow-up.
Symptoms vary according to the type of cancer. They may include unusual vaginal bleeding or discharge, persistent pelvic pain or pressure, bloating, abdominal discomfort, feeling full quickly, urinary or bowel changes, or changes affecting the vulva.
These symptoms can also occur with conditions other than cancer, so persistent or unusual symptoms should be medically evaluated.
No. Unusual bleeding can have many causes and does not automatically mean cancer. However, abnormal bleeding should be discussed with a doctor, particularly bleeding after menopause or bleeding that is unusual for you.
No. Cervical cancer is the gynaecological cancer for which established screening tests are available. There is currently no reliable routine screening test for ovarian cancer in women without symptoms.
Screening and diagnostic testing are different. Diagnostic tests are used when symptoms or other findings require investigation.
Diagnosis may involve a medical history, physical or pelvic examination, imaging, blood tests and tissue sampling. The exact investigations depend on the suspected cancer.
When cancer is suspected, a biopsy or surgical tissue specimen may be examined by a pathologist to establish the diagnosis.
The need for tissue diagnosis depends on the suspected cancer and clinical situation. Many gynaecological cancers require tissue examination to confirm the diagnosis and determine important pathological characteristics.
For example, endometrial cancer is diagnosed by examining endometrial tissue, while suspicious cervical, vaginal or vulvar lesions may require biopsy.
Stage describes the extent of cancer in the body, including whether it has spread to nearby tissues, lymph nodes or distant sites.
Grade describes how abnormal the cancer cells look under a microscope and provides information about the characteristics of the tumour.
Treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy or hormone therapy.
Some patients receive one treatment, while others need a combination. Treatment depends on the cancer type, stage, pathology, biomarkers, previous treatment and overall health.
Not necessarily. Surgery is an important treatment for several gynaecological cancers, but whether it is appropriate depends on the cancer type, stage and individual circumstances.
Some cancers may be treated primarily with radiation and/or systemic treatment instead of surgery.
Chemotherapy uses anti-cancer medicines that circulate through the body. It may be used before or after surgery, together with radiation in selected cancers, or to treat advanced or recurrent disease.
Radiation therapy may be used as a primary treatment, after surgery, together with chemotherapy, or to control symptoms in selected advanced cancers.
Depending on the cancer, radiation may be delivered externally, internally through brachytherapy, or using both approaches.
Yes. Immunotherapy and targeted therapy are treatment options for selected gynaecological cancers and clinical situations. Their use depends on the cancer type, stage, previous treatment and relevant tumour or molecular characteristics.
Fertility-preserving treatment may be possible for selected patients, particularly in certain early-stage cancers. However, it is not suitable for everyone.
If future pregnancy is important to you, discuss fertility preservation before treatment begins so that appropriate options can be considered.
Yes. A second oncology opinion can involve review of the pathology, imaging, diagnosis and proposed treatment plan.
Bring your pathology reports, imaging reports and images, previous treatment records and relevant medical information to the consultation.
Different specialists contribute different areas of expertise. Surgical oncology may assess surgery, medical oncology manages systemic treatments, and radiation oncology plans radiation treatment when appropriate.
Working across these specialities can help integrate different parts of the treatment plan.
Bring your biopsy and pathology reports, scan reports and available imaging, previous treatment records, current medication list and relevant medical history.
Writing down your questions in advance can also help ensure that important concerns are discussed during the consultation.
Follow-up depends on the cancer type and treatment received. It may include clinical examinations, monitoring for symptoms, investigations when clinically indicated and management of treatment-related effects.
Follow-up also provides an opportunity to address longer-term health, reproductive, emotional and quality-of-life concerns.
Discuss your diagnosis, pathology, treatment options and next steps with an oncology team after reviewing your medical records and investigations.
Precision Oncology Clinic, the best Cancer Clinic in Bangalore, located in Vijayanagar. Book appointment!
漏2024. All Rights Reserved. Precision Oncology Clinic
By HAAPS
Book Appointment